A1's Top 5 Most Undervalued Nasdaq Stocks,
Using Our DDDD: (Deep Dive Due Diligence)
5 Stocks With Undeniable
Massive Upside Potential
Updated Jan 21st, 2026
Let's begin by saying that any investment is risky.
Before investing in anything, do your own due diligence. Only you can click the "Buy" button.
Anything can happen: When Covid news went worldwide in March 2020, even the greats tumbled:
Tesla fell to $103. Boeing fell to $113 pre-market.
The Stock Market can be quite irrational.
Stocks like HKD can run high, too,
like it did from $10 to $2,550 in just 3 days in 2022.
This is not a "paid advertisement", it is a free service
we offer to our portfolio clients, and share with our followers in the investing public as well.
At A1 we envision a day where stocks become valued by
share price as they should be. The "Correction" is what
we're seeing right now in the Market. Wrongly inflated stocks tumble, money moves to value.
We help investors choose wisely--It's why our readership is steadily increasing.​​
​​Here are our current "Top 5 Most Undervalued Stocks", after our "Deep Dive of Due Diligence".
First off, when you research undervalued companies,
the Chinese firms always lead the pack. So, why do we not include them here? Because history shows the valuations and financial are almost always skewed, perhaps by fraud, (remember QMMM?), perhaps by poor accounting, perhaps by confusing ADR ratios, Kerry Trade issues, CONFUSING Yuan Exchange Rates, perhaps all of the above. It's a reality of the Stock Market. See OCG & SXTC for the most recent catastrophic collapses!
So we're keeping our list to U.S. companies ONLY:
:
#1 American Rebel Inc (AREB)
It happened again last night. This "beaten-down-by-bears" stock announced a dividend of a lifetime, normally, 20x stock dividend in effect on Feb 2nd. Those who got in at .36 when it bottomed out hit the jackpot, it hit .83 after hours last night
(Jan 21st). Instead of having your stock amount deplete to 1/20th of what you have, it stays the same (!!!) and the stock price will start at 20x on Feb 2nd. The last time they offered
this, those that got in early cleaned up, in a huge way.
And now, almost out of shares to borrow, a short squeeze
will add to the frenzy.
The stunning thing is, even without the 20x dividend, the stock
is a strong candidate for most undervalued. Per Finviz, it holds
a $6.38/share Book Value (What a buy out would cost the buyer) and an Enterprise Value (What the world values the company at based on financials and operations) at $22.63 million, about 1/7th of the Market Cap...around $4.20/share.
Add in the fact that the "American Rebel Light drinkers will be going wild with the Super Bowl coming soon, when every year money flow always accelerates due to the "gaming" mindset, this could far surpass our $3 price target (which =$60 on Feb 2nd).
Jan 21st AH close: $.63 Our PT=$60 on Feb 2 (9,523% realistic upside potential.)​​
​
#2 ELAB PMGC Holdings Inc.
Headquartered in beautiful and affluent Newport Beach, CA,
this conglomerate is operating with a brilliant business plan.
Where would seem like "fracturing: to the old way of thinking,'
in today's economy what PMGC is doing is "bootstraping" with income producing subsidiaries, and income producing INVESTMENTS:
They own 1,639,521 shares of CITR, purchased for around a $2.75 average per share, now worth around $7.59/share!
Earning about $8 million from just that.
They have a list of parts, too, subsidiaries, mega cash, and their core company:
​
Subsidiary / Cash Valuation Table
Component Value w/ Per-Share Value
(Based on the 500K OS & 460K float:)
​
Cash (unrestricted) $7.1 M = $14.20/sh
AGA Precision Systems LLC =$0.40/sh
Pacific Sun Packaging Inc =$0.90/sh
CMC Aerospace =$0.50/sh
NorthStrive BioSciences = $1.00/sh
PMGC Research Inc. =$0.30/sh
PMGC Capital LLC =$0.40/sh
CITR Ownership =$25.38/sh
​
This above is not including the undisclosed stake in the nuclear company MMR. Anything "nuclear" nowadays has clear stock rocket potential, even just holdings.
-Aerospace contracts are rumored imminent now with the newly acquired ISO AS9100.
For small caps, this Certification achievement is RARE,
this PR was extremely under recognized as HUGE,
as LUCRATIVE Aerospace contracts can come at any moment.
Think of the recent "skyrocketing" successes of RKLB, ASTS, SIDU, LUNR, and others. SpaceX will be the largest IPO in history, said to be $30B or more...With a valuation of $1T to $1.5T.​
Curr $3.42 Our PT=$43.08 (1,259% realistic upside potential.)
#3 SHPH Shuttle Pharmaceuticals
SHPH has our attention with not only the bargain price of
under $2/sh, but ongoing events as well:-SHPH shot up like a space shuttle 400% in a previous Friday's pre-market trading...due to the 50% gioblastoma trial enrollment PR. The results from Phase 1 were astounding.-Also this recent PR: "Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer".-High "Insider Ownership" is always a very good sign, SHPH boasts 46.58% plus 5+% institutionally owned. SHPH also presented in Las Vegas in April. These two life and health enhancing companies have bright futures, and mathematically equal upsides...a first at A1.
A Reverse Split and offering were completed recently, so they're compliant and fully funded now.
The recently acquired Molecule A.I. platform can be a game
changer in the fight against cancer, in which Shuttle has an even
greater chance now, of curing.
Curr=$2.02 PT =$6.72 (333% realistic upside potential.)
​
#4 IXHL Incannex Healthcare Inc.
The sequential, and almost concurrent PRs of "Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X" and "Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilize ATM in Near Term​"
and backing by this Benzinga article
"Nano-Cap Incannex's Sleep Apnea Candidate Shows Effectiveness And Safety In Mid-Stage Trial"
PRs came just 48 days after another important PR: "Incannex Healthcare Cancels All Outstanding Series A Warrants". With a respectable 21.94% insider ownership, now solid balance sheet, gangbuster trial results, and clearly a dedicated following, this stock is now clearly QUITE undervalued. A "short squeeze" is in the cards, as Dark Pool greed will most likely backfire on the Bears.
Curr=$.3518 =$1.13 (323% realistic upside potential.)​
​
​​#5 EKSO Ekso Bionics Holdings, Inc.
Ekso has been on our list , and has more than doubled since! Due to this outstanding mix of upward pointing reasons: Robotics-Health Care (foremostly spine care, which is the largest $$$ HC industry, see #1 Aclarion).A.I., a partnership with Nvidia in their prestigious ConnectProgram, a very small 2.11 million share float, EXISTING SALES of $17.54 million/yr, and overall decent relative financials. Yahoo Finance PREVIOUSLY gave it an average of a $37.50 longer term price target, also due the major positives Ekso brings...Possible upcoming dilution may lower that a bit.
Curr=$8.17 PT =$11.60 (140% realistic upside potential.)​​
​
​